ImmunoGen is now part of AbbVie. AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates. Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
View Top Employees from ImmunoGen, Inc.Website | http://www.abbvie.com/ |
Ticker | IMGN |
Revenue | $82 million |
Funding | $866 million |
Employees | 397 (396 on RocketReach) |
Founded | 1981 |
Address | 1 N Waukegan Rd, North Chicago, Illinois 60064, US |
Phone | (781) 895-0600 |
Fax | (781) 895-0611 |
Technologies |
JavaScript,
HTML,
PHP
+63 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Education General, Biotechnology, Education, Science and Engineering, Health Care, Medical |
Keywords | Biotechnology, Cancer Therapeutics, Immuno-Oncology, Targeted Cancer Therapies, Drug Development And Manufacturing, Clinical Trials, Oncology, Hematologic Malignancies, Solid Tumors |
Competitors | InteRNA Technologies BV, Mersana Therapeutics, Nordic Nanovector ASA, Sunesis Pharmaceuticals, Inc., U3 Pharma GmbH |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 5413 Companies, NAICS Code 54199 Companies, NAICS Code 54 Companies, NAICS Code 54138 Companies, NAICS Code 541 Companies, NAICS Code 5419 Companies |
Looking for a particular ImmunoGen, Inc. employee's phone or email?
The ImmunoGen, Inc. annual revenue was $82 million in 2024.
396 people are employed at ImmunoGen, Inc..
ImmunoGen, Inc. is based in North Chicago, Illinois.
The NAICS codes for ImmunoGen, Inc. are [5413, 54199, 54, 54138, 541, 5419].
The SIC codes for ImmunoGen, Inc. are [283, 28].